Electronic Prescribing for Controlled Substances

Integrating Electronic Prescribing for Controlled Substances (EPCS) within existing technology and workflows offers new dimensions of safety and security.

Addresses opioid fraud and abuse

Sends prescriptions for controlled substances electronically and securely from prescriber to pharmacy

Increases prescribing workflow efficiency

Reduces pharmacy and provider callbacks to clarify intent

Improves patient safety

Helps providers make the best-informed care decisions for patients who may be at risk of abuse or overdose of controlled substances

Maintains regulatory compliance

Ensures that providers are in compliance with existing legislation

Learn more

Long-term & post-acute care

Surescripts brings greater prescription accuracy and efficiency to long-term and post-acute care workflows with electronic prescription transactions including Census and Resupply.

Broad access to facilities

A single connection enables communication with multiple long-term and post-acute care facilities, making direct connections unnecessary.

Improves prescription accuracy

Streamlined, EHR-integrated e-prescribing delivers unmatched accuracy, efficiency and value.

Gives time back to patient care

A reduction in phone calls, faxes and manual transcription means more time spent with patients.

Related content

Read This: ‘Standard Bearers’ in E-Prescribing: CancelRx and RxTransfer

Read This: In Prescription Accuracy, the Patient is the Point

Read This: Electronic Prescribing for Controlled Substances: 20 Years of Persistence and Progress

Get certified for E-Prescribing

This form is for healthcare technology vendors who wish to request Surescripts certification on their e-prescribing solution. Physicians, please do not complete this form. Contact your EHR vendor for more information on their e-prescribing capabilities or view a list of Surescripts-certified prescriber software.

  1. “E-Prescribing with Decision Support Is Associated with Improvements in Medication Adherence," American Journal of Pharmacy Benefits, July/August 2016
  2. Surescripts, “2020 National Progress Report,” April 2021.